Reta 10mg
$150.00
Reta 10mg
Reta is an investigational triple-receptor agonist peptide targeting GLP-1, GIP, and glucagon receptors, showing substantial weight loss in trials but lacking regulatory approval alongside urgent health warnings regarding severe liver toxicity from black-market products.
How It Works in Trials
- GLP-1 receptor: reduces appetite and slows stomach emptying.
- GIP receptor: improves insulin release and blood sugar control.
Glucagon receptor: increases energy expenditure and fat burning.